Publication | Closed Access

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

Pancreatic CancerGastrointestinal OncologyMedicinePharmacologyPharmacotherapyAdvanced Pancreatic CancerCancer TreatmentFolfirinox Induction ChemotherapyOncologyRadiation OncologyMolecular OncologyGemcitabine Versus